# Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus

> **NCT00187564** · NA · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 40 (—)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** controlled-release oral alpha-lipoic acid

## Key facts

- **NCT ID:** NCT00187564
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 40 (—)
- **Last updated:** 2008-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00187564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00187564, "Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00187564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
